The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor (pasireotide) for the treatment of patients with Cushing's disease who require medical therapeutic intervention.
URL: http://www.news-medical.net/news/20121107/FDA-EMDAC-votes-unanimously-in-support-of-Signifor-use-for-treatment-of-Cushings-disease.aspx
No comments:
Post a Comment